Can Dientamoeba fragilis act as a chronic intestinal antigen causing eosinophilia and pruritic skin?

Dientamoeba fragilis (D. fragilis) is a common yet often overlooked intestinal protozoan that can establish persistent infections. While frequently asymptomatic, emerging evidence suggests it may act as a chronic intestinal antigen capable of triggering systemic immune responses, including eosinophilia and dermatological symptoms, in a subset of patients.

Clinical and immunological evidence

The association between D. fragilis and systemic immune activation is primarily supported by clinical observations of peripheral blood eosinophilia and rare cases of extraintestinal symptoms.

• Eosinophilia: Clinical studies report peripheral eosinophilia in 24.1% to 50% of infected patients, particularly in pediatric populations. While eosinophilia is more characteristically associated with helminth (worm) infections, its prevalence in D. fragilis cases—even in the absence of documented co-infections—points toward a significant host immune response.
• Dermatological manifestations: Pruritic skin conditions, such as chronic urticaria (hives), have been linked to D. fragilis in isolated clinical reports. In one study of children with chronic urticaria, eradication of the parasite led to the complete resolution of skin symptoms, suggesting the infection was the primary trigger for the allergic-type manifestation.
• Chronicity: D. fragilis often establishes long-term colonization, with 32% to 52% of patients experiencing symptoms for more than two weeks, and many for much longer. This persistence allows the parasite to function as a source of chronic antigenic stimulation within the intestinal crypts.

Mechanistic explanations

The link between this intestinal protozoan and systemic symptoms like pruritus (itching) is hypothesized to occur through a Th2-mediated immune pathway.

• Th2 immune activation: Chronic exposure to D. fragilis antigens may stimulate a Type 2 helper T-cell (Th2) response. This pathway typically involves the release of cytokines such as IL-4 and IL-5, which drive the production and activation of eosinophils and potentially IgE.
• Systemic sensitization: Although D. fragilis is considered non-invasive, it can induce significant inflammatory changes and eosinophilic infiltration in the colonic mucosa. This localized inflammation may lead to systemic sensitization, where immune mediators circulate and manifest as pruritic skin reactions in susceptible individuals.

Limitations and considerations

While the associations are clinically documented, interpreting the role of D. fragilis requires caution due to frequent co-pathogens.

• Co-infection confounding: D. fragilis is frequently found alongside Enterobius vermicularis (pinworm), a helminth known to independently cause both eosinophilia and pruritus. This makes it difficult to definitively attribute these symptoms solely to D. fragilis in all cases.
• Variable pathogenicity: Not all strains of D. fragilis appear to be equally pathogenic, which may explain why only a small subset of infected individuals develops extraintestinal symptoms.

Bottom line

D. fragilis can act as a chronic intestinal antigen associated with eosinophilia and pruritic skin manifestations. While these extraintestinal symptoms are relatively rare, the resolution of skin conditions following successful antiparasitic treatment suggests that D. fragilis should be considered a potential trigger in patients presenting with unexplained eosinophilia or chronic urticaria.